ATE138077T1 - Synthetisches antigen zum bewirken einer anti-hiv-reaktion - Google Patents

Synthetisches antigen zum bewirken einer anti-hiv-reaktion

Info

Publication number
ATE138077T1
ATE138077T1 AT89903389T AT89903389T ATE138077T1 AT E138077 T1 ATE138077 T1 AT E138077T1 AT 89903389 T AT89903389 T AT 89903389T AT 89903389 T AT89903389 T AT 89903389T AT E138077 T1 ATE138077 T1 AT E138077T1
Authority
AT
Austria
Prior art keywords
producing
synthetic antigen
hiv
hiv response
response
Prior art date
Application number
AT89903389T
Other languages
English (en)
Inventor
Jay A Berzofsky
Hidemi Takahashi
Anne Hosmalin
Ronald A Germain
Bernard Moss
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE138077T1 publication Critical patent/ATE138077T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89903389T 1988-01-26 1989-01-17 Synthetisches antigen zum bewirken einer anti-hiv-reaktion ATE138077T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14869288A 1988-01-26 1988-01-26

Publications (1)

Publication Number Publication Date
ATE138077T1 true ATE138077T1 (de) 1996-06-15

Family

ID=22526912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903389T ATE138077T1 (de) 1988-01-26 1989-01-17 Synthetisches antigen zum bewirken einer anti-hiv-reaktion

Country Status (8)

Country Link
EP (1) EP0400076B1 (de)
JP (1) JP2569185B2 (de)
AT (1) ATE138077T1 (de)
AU (1) AU621097B2 (de)
CA (1) CA1340907C (de)
DE (1) DE68926499T2 (de)
IL (1) IL89012A (de)
WO (1) WO1989007112A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6656471B1 (en) 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
US7189800B2 (en) 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US7774144B2 (en) 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
KR101067654B1 (ko) * 2001-07-09 2011-09-26 엘레노어 에스 보고치 레플리킨 펩타이드 및 그의 이용
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
EP2092059A4 (de) 2006-10-24 2012-03-28 Bogoch Samuel Verfahren zur vorhersage von influenza-ausbrüchen durch korrelation eines erhöhten replikin-spiegels in white-spot- und/oder taura-viren bei krabben
MX2009013091A (es) 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387915B1 (de) * 1984-10-18 1993-03-10 Institut Pasteur F Antigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them

Also Published As

Publication number Publication date
CA1340907C (en) 2000-02-22
WO1989007112A1 (en) 1989-08-10
IL89012A (en) 1993-07-08
JPH03503166A (ja) 1991-07-18
DE68926499D1 (de) 1996-06-20
JP2569185B2 (ja) 1997-01-08
EP0400076A1 (de) 1990-12-05
AU3204489A (en) 1989-08-25
EP0400076A4 (en) 1991-11-13
DE68926499T2 (de) 1996-12-19
EP0400076B1 (de) 1996-05-15
AU621097B2 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
DE68926499D1 (de) Synthetisches antigen zum bewirken einer anti-hiv-reaktion
NO890103L (no) Fremgangsmaate for fremstilling av levende vaksine mot coccidiosis.
DE68911294D1 (de) Mikrobearbeiteter beschleunigungsmesser.
PT89635A (pt) Processo para a preparacao de contrastes para ultrassons
IT1236688B (it) Procedimento e dispositivo per la creazione di una miscela combustibile-aria comburente da addurre a una combustione.
DE3783068D1 (de) Medizinische vorrichtung.
ES533263A0 (es) Procedimiento para la preparacion de una vacuna neumococcica multivalente.
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
NO166522C (no) Fremgangsmaate for aa forbedre den mekaniske styrke av et finerark.
IT8019341A0 (it) Procedimento per la preparazione di latici di copolimeri acetato di vinile/etilene e latici ottenuti mediante detto procedimento.
IT1067959B (it) Laminato tessile,nonche' procedimento e dispositivo per la sua fabbricazione
SE7512828L (sv) Calicivirusvaccin
ES2063154T3 (es) Vacuna asociada por afinidad.
IT1064609B (it) Impianto endoosseo individuale per odontostomatologia e attrezzo per la rapida e perfetta applicazione al paziente
DK504389D0 (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
DE69516180D1 (de) Norbornen-verbindungen die polyen-ketten enthalten und ungesättigte ethylenische copolymere die unter zuhilfenahme dieser verbindungen hergestellt sind
EP0222302A3 (en) Strain of aureobasidium pullulans, preparation process and use
ES2059784T3 (es) Derivado antigeno de la estreptolisina o, su produccion y usos.
IT7928087A0 (it) Procedimento e dispositivo per la coagulazione di un lattice acquoso di un polimero.
IT8022185A0 (it) Strumento per la cura dei piedi di notevole versatilita' di uso.
FI890760A7 (fi) Menetelmä bis(3,5-dioksopiperatsinyyli)alkaanien tai -alkeenien valmistamiseksi
SE7708780L (sv) Fluorsulfonyloxafluoroalkaner, deras derivat, fluorosulfonylolefiner, deras sampolymerer och forfarande for framstellning derav
IT8719565A0 (it) Procedimento e dispositivo per produrre una giuntatura.
IT7821727A0 (it) 3-ammino-1-sostituito-1, 2,4-benzotiadiazin-1-ossido, utile quale agente ipotensivo, eprocedimento per la sua preparazione.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time